What is the Market's View on Pfizer Inc (PFE) Stock's Price and Volume Trends Monday?

Overall market sentiment has been high on Pfizer Inc (PFE) stock lately. PFE receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Pfizer Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on PFE!

See Full PFE Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With PFE Stock Today?

Pfizer Inc (PFE) stock is trading at $27.71 as of 11:20 AM on Monday, Apr 1, a drop of -$0.05, or -0.16% from the previous closing price of $27.75. Volume today is below average. So far 7,693,327 shares have traded compared to average volume of 43,593,662 shares. The stock has traded between $27.60 and $27.87 so far today.

More About Pfizer Inc

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor. Click Here to get the full Stock Report for Pfizer Inc stock.